Dark

TARS
Tarsus Pharmaceuticals, Inc. Common Stock
stock NASDAQ

At Close

Dec 30, 2025 3:59:45 PM EST

82.18USD+0.250%(+0.21)1,446,636

81.92Bid 82.03Ask 0.11Spread

Pre-market

Dec 30, 2025 8:50:30 AM EST

82.07USD+0.122%(+0.10)4,165

After-hours

Dec 30, 2025 4:19:30 PM EST

82.33USD+0.189%(+0.15)979,862

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

3.50B

Industry

Biotechnology

TARS Stats

Avg. Vol. 10 Day

713,476

Avg. Vol. 30 Day

519,581

Employees

Market Cap

3,496,957,270

Shares Out.

42,449,105

On/Off Exchange

44%/56%

6 Month Beta

0.48

1 Year Beta

0.55

2 Year Beta

0.68

3 Year Beta

0.70

52 Week Low

38.51

52 Week High

85.25

SMA50

75.93

SMA200

55.78

1 Week

+0.30%

1 Month

+3.01%

3 Month

+38.62%

6 Month

+103.36%

1 Year

+50.60%

2 Year

+306.82%

5 Year

+96.52%

Profile

tarsus pharmaceuticals, inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. its lead product candidate is tp-03, a novel therapeutic that is in phase iib/iii for the treatment of blepharitis caused by the infestation of demodex mites, as well as to treat meibomian gland disease. the company is also developing tp-04 for the treatment of rosacea; and tp-05 for lyme prophylaxis and community malaria reduction. tarsus pharmaceuticals, inc. was founded in 2016 and is headquartered in irvine, california.

TARS Stock Summary

Tarsus Pharmaceuticals, Inc. Common Stock (NASDAQ:TARS) stock price today is $82.18, and today's volume is 1,446,636. TARS is up 0.250% today. The 30 day average volume is 519,581. TARS market cap is 3.50B with 42,449,105 shares outstanding.

.dark-mode .lr0dlB{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .lr0dlB{ color: #333333; background-color: white; border: 2px solid #333333; }TARSTarsus Pharmaceuticals, Inc. Common Stockstock NASDAQ

TARS Stock Summary

TARS
Tarsus Pharmaceuticals, Inc. Common Stock
stock NASDAQ